By Kyle Morris

 

Creo Medical Group PLC said Monday that it has signed a long-term, multiyear collaboration agreement for the use of its technology with Intuitive Surgical Inc.'s robot-assisted surgical platform.

The London-listed medical-device company said that the collaboration provides a framework for joint clinical studies and includes milestone payments and royalty structures for any products which may be sold in the future.

Shares in Creo at 0822 GMT were up 2.00 pence, or 2.1%, at 98.00 pence.

 

Write to Kyle Morris at kyle.morris@dowjones.com

 

(END) Dow Jones Newswires

May 23, 2022 04:46 ET (08:46 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Creo Medical (LSE:CREO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Creo Medical Charts.
Creo Medical (LSE:CREO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Creo Medical Charts.